MedTrace Logo

PMCF Study of the CLS Brevius Stem With Kinectiv Technology

NCT03410940 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 223

Last updated 2020-12-17

No results posted yet for this study

Summary

This study is a multi-center, prospective, non-controlled post-market surveillance study. The primary objective of this study is to confirm the safety and performance of the CLS Brevius stem with Kinectiv technology by obtaining implant survivorship and clinical outcomes data for the commercially available stem.

Conditions

Interventions

DEVICE

CLS Brevius stem with Kinectiv technology

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Paola Vivoda · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-07
Primary Completion
2019-04-08
Completion
2020-12-14
FDA Device
Yes

Countries

  • Italy
  • Poland
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03410940 on ClinicalTrials.gov